老夫子传媒

漏 2024 | 老夫子传媒
Southern Oregon University
1250 Siskiyou Blvd.
Ashland, OR 97520
541.552.6301 | 800.782.6191
Listen | Discover | Engage a service of Southern Oregon University
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

With youth overdose death rates soaring, Oregon offers free opioid reversal medication to schools

The Oregon Health Authority plans to provide opioid overdose reversal kits to schools across the state. The kits naloxone, shown in this 2020 file photo, a drug that helps someone overdosing from fentanyl or other opioids.
Kristian Foden-Vencil
/
OPB
The Oregon Health Authority plans to provide opioid overdose reversal kits to schools across the state. The kits naloxone, shown in this 2020 file photo, a drug that helps someone overdosing from fentanyl or other opioids.

The initiative comes amid a big jump in the number of teens who鈥檝e died from drug overdoses in the last five years. 

The Oregon Health Authority has turned its focus to the state鈥檚 skyrocketing rate of opioid overdoses among young people by offering free opioid reversal medication to schools.

The agency announced this week that it is expanding an initiative launched in 2020 that has distributed harm reduction supplies to more than 280 organizations and agencies statewide. This new emphasis by Save Lives Oregon focuses on middle schools, high schools, colleges and universities. The initiative is offering three free kits of naloxone, an opioid overdose reversal medication, to schools that serve children at least 7 years old. Each wall-mounted kit contains eight doses.

鈥淭he intent is to help school districts increase access to overdose reversal kits with their schools for use in the event of an opioid overdose emergency at or near a school campus,鈥 a news release said.

The initiative comes amid a record rate of teen overdoses over the last five years. From 2018 through 2022, drug deaths among teens aged 15 to 19 soared 550% 鈥 the fastest-growing rate in the U.S., based on Centers for Disease Prevention and Control data a parent advocate, Jon Epstein. Over the same time period, nearly 300 people aged 15 to 24 died from a drug overdose 鈥 giving Oregon a higher death rate among young people than the national average.

Epstein and his wife, Jennifer, became involved in fighting drug use and overdoses among young people after their 18-year-old son Cal died in 2020 from counterfeit pills containing fentanyl. The drug, 50 times more potent than heroin, is driving the current epidemic. CDC data shows that all of teen drug deaths in 2022 involved synthetic opioids, or fentanyl.

Epstein, who combs through CDC data as part of his , said naloxone 鈥渋s not a silver bullet鈥 because it doesn鈥檛 treat or prevent drug addiction. It鈥檚 only purpose is to keep people alive. But he said that might be all it takes to shock a teen away from drugs.

鈥淲e should absolutely have it in all schools, and if it鈥檚 free and easy to get this way, that鈥檚 fantastic,鈥 Epstein said. 鈥淚t should also be in every medicine cabinet and on every school bus.鈥

The medication needs to be easily available for quick application.

鈥淏rain damage can occur within minutes of overdosing from fentanyl,鈥 said Dr. Todd Korthuis, head of addiction medicine at Oregon Health & Science University. 鈥淢aking naloxone available in schools decreases the time to reverse an overdose in teens who use fentanyl.鈥

The agency first offered the kits on Nov. 29, and so far more than 500 have requested them. They鈥檙e being paid for by up to $693,000 of the state鈥檚 opioid settlement funds, which were first distributed in 2022 and total $325 million over 18 years.

The teen drug rate outpaces that of all other age groups in Oregon. The second highest increase between 2018 and 2022 was 333% among those 70 to 74 years old, and the third highest increase was about 225% among those 30 to 34 and 40 to 44.

No immediate impact

Some school districts already have naloxone on hand, like the It has trained staff to administer the drug, which is often injected into a victim鈥檚 thigh or another large muscle. The district was the first statewide to launch classes for middle and high schoolers on the dangers of fentanyl. , which was proposed by Sen. Chris Gorsek of Gresham and passed by the Legislature, requires Oregon schools to adopt by next July similar curricula being developed by the Oregon Health Authority, State Board of Education and Alcohol and Drug Policy Commission.

Another measure, which was championed by Rep. Maxine Dexter of Portland and passed by lawmakers, aims to make naloxone more widely available. It includes a provision authorizing school administrators, teachers or staff to administer the drug to students experiencing an opioid overdose without written permission from the parent.

Although Epstein supports the initiative, he said more is needed than putting naloxone in schools.

鈥淪chools are pretty safe places, but they鈥檙e not necessarily where kids are overdosing,鈥 Epstein said. 鈥淚n a school, it is like having an EpiPen, but it is not going to dramatically change the overdose death rate.鈥

Epstein wants the state to focus on 鈥渦pstream鈥 initiatives, like those recommended by the Centers for Disease Control and Prevention. They include reducing the availability of illicit drugs, awareness and education campaigns, harm reduction and mental health and addiction treatment.

鈥淩aising awareness in schools about the life-threatening risks of fake pills containing fentanyl will help teens avoid unintentional exposure to fentanyl,鈥 Korthuis said.

The  is a professional, nonprofit news organization. We are an affiliate of , a national 501(c)(3) nonprofit supported by grants and a coalition of donors and readers. The Capital Chronicle retains full editorial independence, meaning decisions about news and coverage are made by Oregonians for Oregonians.

Lynne Terry has more than 30 years of journalism experience. She reported on health and food safety in her 18 years at The Oregonian, was a senior producer at Oregon Public Broadcasting and Paris correspondent for National Public Radio for nine years.